BOT 13.0% 13.0¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received

  1. lightbulb Created with Sketch. 851
    • Release Date: 18/12/18 09:43
    • Summary: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
    • Price Sensitive: Yes
    • Download Document  177.02KB
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
13.0¢
Change
0.015(13.0%)
Mkt cap ! $100.5M
Open High Low Value Volume
13.0¢ 13.0¢ 12.5¢ $641.8K 4.967M

Buyers (Bids)

No. Vol. Price($)
1 30000 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 629500 15
View Market Depth
Last update - 16.10pm 14/06/2019 (20 minute delay) ?
(live)
Last
13.0¢
  Change
0.015 ( 8.33 %)
Open High Low Volume
13.0¢ 13.0¢ 12.5¢ 995520
Last updated 15.59pm 14/06/2019 (live) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.